Impact of chemogenetic activation of dorsal vagal complex astrocytes in mice on adaptive glucoregulatory responses
dc.contributor.author | MacDonald, AJ | |
dc.contributor.author | Pye, KR | |
dc.contributor.author | Beall, C | |
dc.contributor.author | Ellacott, KLJ | |
dc.date.accessioned | 2023-09-18T14:03:38Z | |
dc.date.issued | 2023-06-09 | |
dc.date.updated | 2023-09-18T13:52:57Z | |
dc.description.abstract | The dorsal vagal complex (DVC) regulates diverse aspects of physiology including food intake and blood glucose homeostasis. Astrocytes play an active role in regulating DVC function and, by extension, physiological parameters. DVC astrocytes in ex vivo slices respond to low tissue glucose. The response of neurons to low glucose is conditional on intact astrocyte signalling in slice preparations, suggesting astrocytes are primary sensors of glucose deprivation (glucoprivation). Based on these published findings we hypothesised that in vivo DVC astrocyte manipulation with chemogenetics would be sufficient to alter physiological responses that control blood glucose. We found that 2-h after systemic 2-DG-induced glucoprivation there were no observable changes in morphology of glial fibrillary acidic protein (GFAP)-immunoreactive DVC cells, specifically those in the nucleus of the solitary tract (NTS). Chemogenetic activation of DVC astrocytes was sufficient to suppress nocturnal food intake by reducing both meal size and meal number and this manipulation also suppressed 2-DG-induced glucoprivic food intake. Chemogenetic activation of DVC astrocytes did not increase basal blood glucose nor protect against insulin-induced hypoglycaemia. In male mice, chemogenetic DVC astrocyte activation did not alter glucose tolerance. In female mice, the initial glucose excursion was reduced in a glucose tolerance test, suggesting enhanced glucose absorption. Based on our data and published work, we propose that DVC astrocytes may play an indispensable homeostatic role, that is, are necessary to maintain the function of glucoregulatory neuronal circuitry, but alone their bulk activation is not sufficient to result in adaptive glucoregulatory responses. It is possible that there are state-dependent effects and/or DVC astrocyte subsets that have this specialised role, but this was unresolvable using the experimental approaches employed here. | en_GB |
dc.description.sponsorship | Diabetes UK | en_GB |
dc.format.extent | e13315- | |
dc.format.medium | Print-Electronic | |
dc.identifier.citation | Vol. 35(8), article e13315 | en_GB |
dc.identifier.doi | https://doi.org/10.1111/jne.13315 | |
dc.identifier.grantnumber | 19/0006035 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/134022 | |
dc.identifier | ORCID: 0000-0002-4263-0866 (Beall, Craig) | |
dc.identifier | ScopusID: 36175475800 (Beall, Craig) | |
dc.identifier | ORCID: 0000-0001-5261-7465 (Ellacott, Kate LJ) | |
dc.identifier | ScopusID: 6603078325 (Ellacott, Kate LJ) | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / British Society for Neuroendocrinology | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/37370201 | en_GB |
dc.rights | © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en_GB |
dc.subject | astrocyte | en_GB |
dc.subject | brainstem | en_GB |
dc.subject | feeding | en_GB |
dc.subject | glucoprivic | en_GB |
dc.subject | hypoglycaemia | en_GB |
dc.title | Impact of chemogenetic activation of dorsal vagal complex astrocytes in mice on adaptive glucoregulatory responses | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2023-09-18T14:03:38Z | |
dc.identifier.issn | 0953-8194 | |
exeter.article-number | ARTN e13315 | |
exeter.place-of-publication | United States | |
dc.description | This is the final version. Available on open access from Wiley via the DOI in this record | en_GB |
dc.description | Data availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request. | en_GB |
dc.identifier.eissn | 1365-2826 | |
dc.identifier.journal | Journal of Neuroendocrinology | en_GB |
dc.relation.ispartof | J Neuroendocrinol, 35(8) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2023-05-31 | |
dc.rights.license | CC BY | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-06-09 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2023-09-18T14:01:39Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2023-09-18T14:03:39Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2023-06-09 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.